How many insider declarations does 엔젠바이오 have?

엔젠바이오 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 엔젠바이오?

The top reporting insider at 엔젠바이오 is 엔젠바이오, based on the count of public filings.

What is the net insider buy vs sell volume on 엔젠바이오?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

엔

엔젠바이오: directors' dealings · South Korea · DART (FSS)

DART:company-ccbbf3KR·DART (FSS)Mcap 36.6Bn€

AMF ↗

Explore the full directors' dealings record of 엔젠바이오, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Market capitalisation: €36.6bn. The latest transaction was disclosed on 13 March 2026 — Other. Among the most active insiders: 엔젠바이오. All data is openly available.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

1257.00 €

Income statement

Revenue21.24 Bn€

Gross profit3.80 Bn€18% margin

Net income−5.54 Bn€-26.1% margin

Balance sheet & cash

Market cap36.56 Bn€

Total debt33.25 Bn€

Free Cash Flow−8.62 Bn€

Last declaration on 13 March 2026

All Executives1 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations